Lifestyle and Metabolic Factors in Cancer Prevention and Management
In 2026, the link between obesity, insulin resistance, and endometrial cancer is more clearly understood and integrated into patient care. Adipose tissue (body fat) acts as an endocrine organ, converting androgens into estrogen, which can overstimulate the uterine lining.
Consequently, "Metabolic Oncology" has emerged as a supportive field, where patients are prescribed metformin or GLP-1 agonists alongside their cancer treatments to address underlying insulin issues. Clinical data now suggests that aggressive management of metabolic health not only reduces the risk of cancer recurrence but also improves the body's overall response to chemotherapy and immunotherapy.
1 View